Evidence map›Paper›PMID 34354962›Full record

ArticleFrontiers in cellular and infection microbiology2021

A Metatranscriptomics Survey of Microbial Diversity on Surfaces Post-Intervention of cleanSURFACES® Technology in an Intensive Care Unit.

Jeremy Chen See, Truc Ly, Alexander Shope, Jess Bess, Art Wall, Saketram Komanduri, John Goldman, Samantha Anderson, Christopher J McLimans, Colin J Brislawn and 3 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. cleanSURFACESFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jeremy Chen SeeContamination Source Identification, Huntingdon, PA, United States.
Truc LyContamination Source Identification, Huntingdon, PA, United States.
Alexander ShopeContamination Source Identification, Huntingdon, PA, United States.
Jess BessAIONX, Hershey, PA, United States.
Art WallNextflex, San Jose, CA, United States.
Saketram KomanduriUPMC Harrisburg, Harrisburg, PA, United States.
John GoldmanUPMC Harrisburg, Harrisburg, PA, United States.
Samantha AndersonContamination Source Identification, Huntingdon, PA, United States.
Christopher J McLimansContamination Source Identification, Huntingdon, PA, United States.
Colin J BrislawnContamination Source Identification, Huntingdon, PA, United States.
Vasily TokarevContamination Source Identification, Huntingdon, PA, United States.
Justin R WrightContamination Source Identification, Huntingdon, PA, United States.
Regina LamendellaContamination Source Identification, Huntingdon, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital-acquired infections (HAIs) pose a serious threat to patients, and hospitals spend billions of dollars each year to reduce and treat these infections. Many HAIs are due to contamination from workers' hands and contact with high-touch surfaces. Therefore, we set out to test the efficacy of a new preventative technology, AIONX

Indexed as

Cross InfectionDisinfectionHumansIntensive Care UnitsRNA, Ribosomal, 16STechnologyRNA, Ribosomal, 16Scontinuous cleaningHAIhospitalmetatranscriptomicsNGS

Identifiers

PMID34354962
PMCPMC8330600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.